Figure 1.
Percentage of patients with moderate to moderately severe AD showing clinically relevant improvements on the ADAS-cog after 52 weeks.
Notes: *p < 0.05 versus original placebo group; **p = 0.116 versus original placebo group.
Abbreviations: AD, Alzheimer’s disease; ADAS-cog, Alzheimer’s Disease Assessment Scale–Cognitive section.